Skip to Content

Notice

Quarterly List of Guidance Documents at the Food and Drug Administration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a quarterly update of all guidance documents issued and withdrawn since we compiled the last quarterly list of guidance documents that published on March 14, 2000. FDA committed to publishing quarterly updates in our February 1997 “Good Guidance Practices” (GGP's) document, which set forth the agency's policies and procedures for developing, issuing, and using guidance documents. This list is intended to inform the public of the existence and availability of guidance documents issued since the annual comprehensive list was compiled.

DATES:

General comments on this list and on agency guidance documents are welcome at any time.

ADDRESSES:

Submit written comments to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. For information on where to obtain single copies of guidance documents listed here, see the specific center's list of guidance documents.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

LaJuana D. Caldwell, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. Background

In the Federal Register of February 27, 1997 (62 FR 8961), FDA published a notice announcing its “Good Guidance Practices” (GGP's), which set forth our policies and procedures for developing, issuing, and using guidance documents. We adopted the GGP's to ensure public involvement in the development of guidance documents and to enhance public understanding of the availability, nature, and legal effect of our guidance documents.

As part of FDA's effort to ensure meaningful interaction with the public regarding guidance documents, we committed to publishing an annual comprehensive list of guidance documents and quarterly Federal Register notices that list all guidance documents that were issued and withdrawn during that quarter, including “Level 2” guidance documents. The following list of guidance documents represents all guidances that we issued or withdrew since we published the last quarterly list on March 14, 2000 (65 FR 13771). The guidance documents are organized by the issuing center or office within FDA, and are further grouped by the intended users or relevant regulatory activities. Dates provided in the following list refer to the date the guidance was issued or, where applicable, the last date the document was revised. We provided document numbers where available.

II. Guidance Document Issued by the Center for Biologics Evaluation and Research (CBER)

Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityHow to Obtain a Hard Copy of the Document (Name and Address, Phone, FAX, E-mail or Internet)
Draft guidance entitled “International Conference on Harmonsation of Technical Requirements for Registration of Pharmaceuticals for Human Use  M4: Common Technical Document”February 11, 2000FDA Regulated IndustryOffice of Communication, Training, and Manufacturers Assistance (HFM-40), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 1-800-835-4709 or 301-827-1800, FAX Information System: 1-888-CBER-FAX (within U.S.)or 301-827-3844 (outside U.S. and local to Rockville, MD). Internet access: http://www.fda.gov/​cber
Draft Guidance for Industry: Special Protocol AssessmentDecember 1999DoDo
Draft Guidance for Reviewers: Potency Limits for Standardized Dust Mite and Grass Allergen Vaccines: A Revised ProtocolFebruary 2000FDA PersonnelDo
Start Printed Page 33554
Draft Guidance for Industry: IND Meetings for Human Drugs and Biologics: Chemistry, Manufacturing, and Controls InformationFebruary 2000FDA Regulated IndustryDo
Guidance for Industry: Formal Meetings With Sponsors and Applicants for PDUFA ProductsFebruary 2000DoDo
Guidance for Industry: Formal Dispute Resolution: Appeals Above the Division LevelFebruary 2000DoDo
Guidance for Industry: Gamma Irradiation of Blood and Blood Components: A Pilot Program for LicensingFebruary 2000DoDo
Draft Guidance for Industry: Information Program on Clinical Trials for Serious or Life-Threatening Diseases: Establishment of a Data BankMarch 2000DoDo

III. Guidance Documents Issued by the Center for Devices and Radiological Health (CDRH)

Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityDate Withdrawn
Guidance for Industry and for FDA Staff: Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals, Draft Guidance-Not for ImplementationFebruary 8, 2000Office of Compliance (OC)Division of Small Manufacturers Assistance; 1-800-638-2041 or 301-827-0111 or FAX Facts-on-Demand 1-800-899-0381 Internet access: http://www.fda.gov/​cdrh
Guidance for FDA Staff; Compliance Program Guidance Manual; Field Compliance Testing of Diagnostic (Medical) X-ray EquipmentMarch 15, 2000OC/Division of Enforcement I (DOE1)Do
Guidance for Industry and FDA; Guidance for Indwelling Blood Gas Analyzer 510(k) SubmissionsFebruary 21, 2000Office of Device Evaluation (ODE )Do
Guidance on the Use of Standards in Substantial Equivalence DeterminationMarch 12, 2000DoDo
Guidance Document for Premarket Notification Submission for Nitric Oxide Delivery Apparatus, Nitric Oxide Analyzer and Nitrogen Dioxide AnalyzerJanuary 24, 2000ODE/Division of Cardiovascular, Respiratory & Neurological Devices (DCRND)Do
Guidance for Extracorporeal Blood Circuit Defoamer 510(k) SubmissionsFebruary 16, 2000ODE/DCRNDDo
Guidance for Cardiopulmonary Bypass Arterial Line Blood Filter 510(k) SubmissionsFebruary 21, 2000DoDo
Guidance Document for the Preparation of IDEs for Spinal Systems (Replaces: Guidance Document for the Preparation of IDEs for Spinal Systems 8/26/98)January 13, 2000ODE/Division of General & Restorative Devices (DGRD)Do
Guidance for the Arrangement and Content of a Premarket Approval (PMA Application for an Endosseous ImplantMay 16, 1989ODE/Division of Dental, Infection Control and General Hospital Devices (DDIGD)Do
Start Printed Page 33555
Guidance for Industry and FDA Reviewers: Reprocessing and Reuse of Single-Use Devices: Review Prioritization Scheme (Replaces: Reprocessing and Reuse of Single-Use-Devices: Risk Categorization Scheme; Draft Guidance 12/9/99)February 8, 2000DoDo
Guidance for Industry and for FDA Reviewers/Staff; Guidance for the Content of Premarket Notifications for Penile Rigidity Implants (Replaced: Draft Guidance for the Content of Premarket Notifications for Penile Rigidity Implants 5/30/95)January 16, 2000ODE/Division of Reproductive Abdominal, ENT and Radiological Devices (DRAERD)Do
Guidance for Manufacturers Seeking Marketing Clearance of Ear, Nose, and Throat Endoscope Sheaths Used as Protective Barriers (Replaces: Guidance for the Content of Premarket Notification for Disposable, Sterile, Ear, Nose and Throat Endoscope Sheaths with Protective Barrier Claims 10/21/96)March 12, 2000ODE/Division of Ophthalmic and Ear, Nose, Throat Devices (DOED)Do
Draft Guidance for Industry; Guidance on Medical Device Patient LabelingMarch 3, 2000Office of Health and Industry Programs (OHIP)/Division of Device User Programs and Systems Anaylsis (DDUPSA)Do
The FDA Export Reform and Enhancement Act of 1996/Export Certification Package including “Instructions for Requests for Certificate to Foreign Governments” (Replaces: The FDA Export Reform and Enhancement Act of 1996/Export Certification Package including “Instructions for Requests for Certificate to Foreign Governments” 6/22/99)February 7, 2000OHIP/Division of Small Manufacturers Assistance (DSMA)Do
Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #2February 25, 2000OHIP/Division of Mammography Quality and Radiation Programs (DMQRP)Do
Guidance for Industry on the Testing of Metallic Plasma Sprayed Coatings on Orthopedic Implants to Support Reconsideration of Postmarket (Replaces: Guidance for Industry on the Testing of Metallic Plasma Sprayed Coatings on Orthopedic Implants to Support Reconsideration of Postmarket Surveillance Requirements 2/22/99)February 2, 2000Office of Surveillance and Biometrics (OSB)/Division of Postmarket Surveillance (DPS)Do
WITHDRAWALS
Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityDate Withdrawn
Guidance on Medical Device Tracking [FDAMA] Replaced by Guidance for Industry and FDA Staff-Guidance on Medical Device Tracking [FDAMA]February 19, 1998OCJanuary 24, 2000
Guideline for Preparing Notices of Availability of Investigational Medical Devices (Replaced by: Preparing Notices of Availability of Investigational Medical Devices and for Recruiting Study Subjects 3/19/99)November 1, 1985OC/BIMOFebruary 14, 2000
Start Printed Page 33556
Review Proposal for Reagents and Analyzer SystemsMarch 14, 1995ODEFebruary 17, 2000
Implantable Pacemaker Lead Testing Guidance for the Submission of a Section 510(k) Notification (Replaced by: Guidance for the Submission of Research and Marketing Applications for Permanent Pacemaker Leads and for Pacemaker Lead Adaptor 510(k) Submissions 1/14/00)September 1, 1989ODE/DCRNDJanuary 21, 2000
Determining Equivalence of Intraaortic Balloon Catheters Under the 510(k) RegulationsDecember 12, 1989DoApril 7, 2000
510(k) Guidance for Screw Type Endosseous Implants for Prosthetic AttachmentAugust 11, 1992ODE/DDIGDApril 5, 2000
Addendum to Guidance on the Content and Format of Premarket Notification [510(k)] Submissions for General Purpose DisinfectantsMarch 9, 1994DoFebruary 15, 2000
Reprocessing and Reuse of Single-Use-Devices: Risk Categorization Scheme; Draft Guidance (Replaced by: Guidance for Industry and FDA Reviewers: Reprocessing and Reuse of Single-Use Devices: Review Prioritization Scheme Draft 2/8/00December 9, 1999DoFebruary 9, 2000
Draft Guidance on the Content and Format of Premarket Approval Application (PMA) for Sharps Needle Destruction DevicesFebruary 11, 1997DoApril 10, 2000
Sunglass Package; including Certification Statement for the Impact-Resistance Test of Lenses in Eyeglasses and SunglassesMarch 19, 1998ODE/DODFebruary 8, 2000
Guidance for Submission of a 510(k) Premarket Notification for an Air Conduction Hearing AidApril 1, 1991ODE/DRAERDApril 7, 2000
Draft Guidance for the Content of Premarket Notifications for Penile Rigidity Implants (Replaced by: Guidance for Industry and for FDA Reviewer/Staff; Guidance for the Content of Premarket Notifications for Penile Rigidity Implants 1/16/00)May 30, 1995DoMarch 20, 2000
Guidance for the Content of Premarket Notification for Disposable, Sterile, Ear, Nose and Throat Endoscope Sheaths with Protective Barrier Claims (Replaced by: Guidance for the Content of Premarket Notification for Disposable, Sterile, Ear, Nose and Throat Endoscope Sheaths with Protective Barrier Claims 3/12/00)November 21, 1996DoMarch 22, 2000
Draft Guidance to Hearing Aid Manufacturers for Substantiation of ClaimsAugust 5, 1994DoApril 14, 2000
Medical Device Reporting for DistributorsApril 1, 1996OHIP/DSMAFebruary 16, 2000
Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #2 (Replaced by Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #2 2/25/00)March 5, 1999OHIP/DMQRPJanuary 21, 2000
Start Printed Page 33557
The FDA Export Reform and Enhancement Act of 1996/Export Certification Package including “Instructions for Requests for Certificate to Foreign Governments”June 22, 1999DoFebruary 14, 2000
Import of Medical Devices—A Workshop Manual (FDA 93-4228)March 1, 1993DoFebruary 8, 2000
Guidance for Medical Gloves—A Workshop Manual FDA 97-4257 (Replaced by Guidance for Industry and FDA-Medical Glove Guidance Manual Draft FDA 99-4257)September 1, 1997DoDo
Part I—FDA Structure and Functions Part II—Center for Devices and Radiological Health (CDRH) Structure and Functions/International Manual (Replaced by: U.S. FDA-Regulation of Medical Devices; Background Information for International Officials 4/14/99)April 14, 1999OHIP/DSMAFebruary 15, 2000
Part III—FDA's Regulation of Medical Devices/International Manual (Replaced by: U.S. FDA Regulation of Medical Devices; Background Information for International Officials 4/14/99)April 14, 1999OHIP/DSMADo
Part IV—Electronic Access to FDA Guidance Documents and Information/International Manual (Replaced by: U.S. FDA-Regulation of Medical Devices; Background Information for International Officials 4/14/99)April 14, 1999OHIP/DSMADo
MDR Documents Access Information for CDRH Facts-On-Demand (FOD)February 29, 1996OSBDo
MDR Documents Access Information for Industry OrganizationsMay 8, 1996OSBDo
Guidance for Industry on the Testing of Metallic Plasma Sprayed Coatings on Orthopedic Implants to Support Reconsideration of Postmarket Surveillance RequirementsFebruary 22, 1999OSB/DPSJanuary 17, 2000
CORRECTIONS
Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory GroupHow to Obtain a Hard Copy of the Document (Name and Address, Phone, FAX, E-mail or Internet)
Guidance on Premarket Notification [510(k)] Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities (This document was mistakenly listed as “withdrawn” in the March 14, 2000 Federal RegisterAugust 1, 1993ODE/Division of General & Restorative Devices (DGRD)Do

IV. Guidance Documents Issued by the Center for Drug Evaluation and Research (CDER) Start Printed Page 33558

Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityHow to Obtain a Hard Copy of the Document (Name and Address, Phone, FAX, E-mail or Internet)
Skin Irritation and Sensitization Testing of Generic Transdermal Drug ProductsFebruary 3, 2000Generic DrugOffice of Training and Communication, Drug Information Branch, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, Internet access: http://www.fda.gov.cder/​ guidance/index.htm
IND Meetings for Human Drugs and Biologics; Chemistry, Manufacturing, and Controls informationFebruary 4, 2000Chemistry DraftDo
Special Protocol AssessmentFebruary 9, 2000Modernization Act DraftDo
Draft guidance entitled “M4 Common Technical Document: Request for Comments on Initial Components”February 11, 2000ICH Draft—Joint Safety/EfficacyDo
NDAs: Impurities in Drug SubstancesFebruary 25, 2000ChemistryDo
Formal Meetings With Sponsors and Applicants For PDUFA ProductsMarch 7, 2000Modernization ActDo
Formal Dispute Resolution: Appeals Above the Division LevelMarch 7, 2000DoDo
OTC Treatment of Herpes Labialis with Antiviral AgentsMarch 8, 2000Clinical/Medical DraftDo
Conjugated Estrogens, USP: LC-MS Method for Both Qualitative chemical characterization and Documentation of Qualitative Pharmaceutical EquivalenceMarch 9, 2000Biopharmaceutic DraftDo
Content and Format of New Drug Applications and Abbreviated New Drug Applications for Certain Positron Emission Tomography Drug ProductsMarch 10, 2000Modernization Act DraftDo
Information Program on Clinical Trials for Serious or Life-Threatening Diseases: Establishment of a Data Bank: AvailabilityMarch 29, 2000DoDo
Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic ActMarch 30, 2000ProceduralDo
Draft guidance entitled “E11: Clinical Investigation of Medicinal Products in the Pediatric Population”April 12, 2000ICH Draft—EfficacyDo

V. Guidance Documents Issued by the Center for Veterinary Medicine (CVM)

Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityHow to Obtain a Hard Copy of the Document (Name and Address, Phone, FAX, E-mail or Internet)
Guidance for Industry: Development of Supplemental Applications for Approved New Animal Drugs—Draft GuidanceJanuary 2000Animal Drug IndustryCommunications Staff (HFV-12), FDA/CVM, 7500 Standish Pl., Rockville, MD 20855, 301-594-1755, Internet access: http://www.fda.gov/​cvm FAX 301-594-1831
Start Printed Page 33559
Guidance for Industry: Stability Testing for Medicated Premixes GuidanceMarch 2000DoDo

VI. Guidance Documents Issued by the Office of Regulatory Affairs (ORA)

Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityHow to Obtain a Hard Copy of the Document (Name and Address, Phone, FAX, E-mail or Internet)
Draft Guidance for Institutional Review Baords, Clinical Investigators, and Sponsors: Exception from Informed Consent Requirements for Emergency Research.March 30, 2000Regulated IndustryDivision of Compliance Policy (HFC-230), Office of Enforcement, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-857-0420 or Internet access at http://www.fda.gov/​ora/​complianceref/​bimoXerr—guide.htm
Compliance Policy Guide, Chapter 2, Sec.252.110, NEW: Volume Limits for Automated collection of Source PlasmaMarch 6, 2000FDA StaffDo Internet access at http://www.fda.gov/​ora/​complianceref/​cpg/​cpgbio/​ cpg252.110.htm
Compliance Policy Guide, Chapter 2, Sec. 257.100, REVISED: Deferral of source Plasma Donors Due to Red Cell Loss During collection of Source Plasma by Automated PlasmapheresisMarch 22, 2000DoDo—Internet at http://www.fda.gov/​ora/​ compliance—ref/cpg/cpgbio/ cpg257.100.htm
Regulatory Procedures Manual, UPDATE/ REVISION: Chapter 4, Subchapter/ Warning LettersMarch 21, 2000DoDo—Internet at http://www.fda.gov/​ora/​complianceref/​rpmnew2/​ch4.html
Investigations Operation Manual 2000March 2000DoDivision of Emergency and Investigational Operations (HFC-130) Office of Regional Operations, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5636
Memorandum to Import Program Managers—Surveillance and Post Reconditioning Sampling of Bulk Spices for PathogensFebruary 11, 2000DoDivision of Import Operations and Policy (HFC-170), Office of Regional Operations, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD, 301-443-6553
Import AlertsContinuouslyDoFreedom of Information staff (HFI-35), Food and Drug Administration, 5600 Fishers Lane, Rockville MD Internet at http:www.fda.gov/​ora/​fiars/​ ora—import—alerts.html
WITHDRAWALS
Name of DocumentDate of IssuanceGrouped by Intended User or Regulatory ActivityDate Withdrawn
Compliance Policy Guide, Chapter 2, Sec. 215.100 (CPG 7134.07), IND Filings; Completion of Applicable Portions Prior to Final Action on License Applications or License AmendmentsJuly 19, 1976FDA StaffMarch 28, 2000
Start Signature
Start Printed Page 33560

Dated: May 17, 2000.

Margaret M. Dotzel,

Acting Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 00-12989 Filed 5-23-00; 8:45 am]

BILLING CODE 4160-01-F